Blog
Keep up to date with the latest news from Instem.
Application Areas
Clinical Stage
Product
Instem & STP-I Workshop: Preclinical Science in Practice
This workshop reflects a field on the verge of significant change. NAMs, organ-on-chip platforms, and digital pathology are set for greater integration in preclinical toxicology.
Core Challenges of Outdated SCEs, and How to Overcome Them
In this blog, we discuss the hidden cost of PC-SAS, fragmentation, and manual validation.
What inspectors are really looking for
Inspectors expect proof, not promises. Stay inspection ready with continuous monitoring.
The Gaps Between Your Validated Systems
Why compliant systems still leave compliance blind spots, and what to do about them.
Why Scientific Organizations Are Re-Evaluating Oracle-Based Research Platforms
Modernizing infrastructure without disrupting scientific workflows
Why Applicability Domain Matters in (Quantitative) Structure-Activity Relationship (Q)SAR Models: Supporting Interpretation in Mutagenicity Assessments
Understand how applicability domain affects QSAR prediction confidence and why chemical coverage matters when assessing pharmaceutical impurities under ICH M7.
Inspection Week Shouldn’t Feel Like A Fire Drill
Regulatory inspections shouldn’t require weeks of searching for records, rebuilding audit trails, and pulling teams away from their day-to-day work. This blog explores why organisations are moving from reactive inspection preparation to continuous compliance, and...
Beyond the PPD Label: Clearer Language for Stronger Clinical Trial Transparency Submissions
In this blog, we discuss PPD, what different agencies actually care about, and how to navigate CTT language in an ever-changing regulatory landscape.
